BioPharma, Devices & Diagnostics, Health IT, Startups

Sweat sensors, clinical wearables part of Philly accelerator’s second class

JMC Investment took a majority stake in French medical imaging business in Keosys, a participant in the inaugural class.

ScienceCenter 3401 tech innovtn spaceThere’s definitely a stronger emphasis on clinical facing companies in the Philadelphia-based University City Science Center Digital Health Accelerator’s second batch of startups. Between companies like Invis Alert Solutions with a wearable for institutional settings and Oncora Medical’s personalized cancer radiotherapy only one, GraphWear Technologies, seems to be a direct to consumer model. Half of the companies are women or minority owned.

For a digital health accelerator that only got started at the end of 2014, the inaugural class of University City Science Center’s accelerator has done pretty well. JMC Investment, part of a French American firm JMC Family Office, took a majority stake in French medical imaging business Keosys last fall. Launched in 2001, Keosys was no doubt the most mature of the accelerator participants.  Fit.ly is gearing up for an appearance on Shark Tank next week. Between them, the seven companies created 68 jobs.

The inaugural class and second class have something in common — they’re peppered with alumni from DreamIt Health‘s accelerator.

Here is a summary of the participants:

Grand Round Table emails primary care providers a daily summary about their scheduled patient follow-ups so they can better manage high-risk patients, keeping them out of the hospital. It also joined athenahealth’s More Disruption Please program last year.

Graphwear Technologies developed the first graphene patch which measures dehydration, glucose, and lactic acid levels, all from your sweat.

InvisAlert Solutions uses a wearable device to help care providers monitor patients in institutional settings, improving compliance.

Oncora Medical has a tool for planning personalized cancer radiotherapy, reduces the incidence of toxic radiation side effects in patients and improves cancer center efficiency.

One Health Company is a bit of an outsider here in that it helps to enroll ill pets in clinical trials of cutting-edge therapies. By improving their wellness, the goal is to help develop new therapies for human medicine.

Tissue Analytics transforms the smartphone into a platform for evaluating and measuring things like chronic wounds, burns, and skin conditions.

Photo: Flickr user vic15

Shares0
Shares0